Zealand Pharma A S Is A Biotechnology Company Based In Denmarkfounded In 1998The Company Specializes In Peptide Therapeutics And Is Headquartered In Sa Borgwith Operations In The U Szealand Pharma Focuses On Discoveringdesigningand Developing Peptide Based Medicines For Metabolicgastrointestinaland Rare Diseasesit Has Been Publicly Traded On Nasdaq Copenhagen Since 2010 The Company Utilizes Proprietary Peptide Engineering Platforms To Enhance The Effectiveness And Stability Of Its Drug Candidateszealand Pharma Has Developed Approved Products Such As Adlyxinaand Soliquaa In Collaboration With Sanofifor The Treatment Of Type 2 Diabetesits Pipeline Includes Candidates Like Survodutidecurrently In Phase 3 Trials For Obesityand Petrelintidewhich Is Set To Enter Phase 2 Trials For Obesity In 2024Zealand Pharma Collaborates With Various Pharmaceutical Companiesincluding Boehringer Ingelheim And Astrazenecato Advance Its Therapies For Rare Diseases And Other Conditions
No conferences found for this company.
| Company Name | Zealand Pharma As |
| Country |
Denmark
|
| Address | N/A |
| Telephone | N/A |
| N/A |
